期刊文献+

1,3-偶极环加成反应构建四氢吡咯螺吲哚衍生物及其结构表征

1,3-Dipolar cycloadditions for the synthesis of spirooxindole-based tetrahydropyrroles and its crystal structure characterization
原文传递
导出
摘要 以N-苄基靛红、氨基丙二酸二乙酯和丙烯酸甲酯为原料,在甲苯溶剂中,通过消旋磷酸的催化,在常温搅拌下即可一步合成得到化合物C_(26)H_(28)N_2O_7,实现了多官能团化的四氢吡咯螺吲哚衍生物骨架的构建.其结构通过单晶X射线衍射法确定,晶体属三斜晶系,空间群为P-1,相对分子质量Mr=480.50,晶胞参数a=0.895 73(3)nm,b=0.956 10(2)nm,c=1.503 61(3)nm,V=1.252 31(6)nm^3,Z=2,晶胞密度Dc=1.274g/cm^3,吸收系数μ=0.771mm^(-1),单胞中电子的数目F(000)=508.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子R=0.070 7,wR=0.139 9.在晶体结构中新形成的四氢吡咯环为信封式构象,与吲哚环近似于垂直. The compound C26H28N2O7 has been synthesized by the 1,3-dipolar reaction of N-benzyl isatin,amino-ester and methyl acrylate in toluene under stirring at room temperature catalyzed by racemic phosphoric acid,and achieved the construction of multi-functional spirooxindole-based tetrahydropyrroles skeleton.The structure was determined by single crystal X-ray diffraction.The crystal is triclinic,space group is P-1,with Mr=480.50,a = 0.895 73(3)nm,b = 0.956 10(2)nm,c=1.503 61(3)nm,V = 1.252 31(6)nm3,Z = 2,Dc= 1.274g/mm3,μ= 0.771mm-1,F(000)=508.The structure was solved by direct methods and refined by full-mat rix least squares method to the get final R=0.070 7,ωR =0.139 9.X-ray analysis reveals that the newly formed ring of tetrahydropyrrole in the crystal structure is envelope conformation,and it is similar vertical with indole ring.
出处 《分子科学学报》 CAS CSCD 北大核心 2015年第6期441-445,共5页 Journal of Molecular Science
基金 国家自然科学基金资助项目(51174201) 江苏省自然科学基金资助项目(BK20141129) 江苏高校优势学科建设工程资助项目 徐州工程学院青年专项课题资助项目(XKY2012306)
关键词 1 3-偶极环加成 四氢吡咯 吲哚 晶体结构 1,3-dipolar reaction tetrahydropyrrole indole crystal structure
  • 相关文献

参考文献19

  • 1GIRGIS A S.[J].Eur J Med Chem,2009,44:91-100.
  • 2PERIYASAMI G,RAGHUNATHAN R,SURENDIRAN G,et al.[J].Bioorg Med Chem Lett,2008,18:2342-2345.
  • 3MURUGAN R,ANBAZHAGAN S,SRIMAN NARAYANAN S.[J].Eur J Med Chem,2009,44:3272-3279.
  • 4RANJITH KUMAR R,PERUMAL S,SENTHILKUMAR P,et al.[J].Eur J Med Chem,2009,44:3821-3829.
  • 5KARTHIKEYAN S V,BALA B D,RAJA V P A,et al.[J].Bioorg Med Chem Lett,2010,20:350-353.
  • 6SHI F,LUO S W,TAO Z L,et al.[J].Org Lett,2011,13:4680-4683.
  • 7SHI F,XING G J,TAN W,et al.[J].Org Biomol Chem,2013,11:1482-1489.
  • 8ZHU R Y,WANG C S,ZHENG J,et al.[J].J Org Chem,2014,79:9305-9312.
  • 9SHI F,ZHU R Y,LIANG X,et al.[J].Adv Synth Catal,2013,355:2447-2458.
  • 10SHI F,TAO Z L,LUO S W,et al.[J].Chem.Eur.J.2012,18,6885-6894.

二级参考文献36

  • 1SUNDBERG R J. Indoles[M] Academic Press: San Diego, 1996: 170-175.
  • 2D' ISCHIA M, NAPOLITANO A, PEZZELLA A. Comprehensive Heterocyclic Chemistry I]I[M]. Amsterdam: Elsevier, 2008,353-388.
  • 3CASAPULLO A, BIFULCO G, BRUNO I, et al. [J]. J Nat Prod, 2000, 63(4) : 447-451.
  • 4BAO B, SUN Q, YAO X, et al.[J] J Nat Prod, 2005, 68(5): 711-715.
  • 5KOUKO T, MATSUMURA K, KAWASAKI T. [J] Tetrahedron, 2005, 61(9) : 2309-2318.
  • 6KANIWA K, ARAI M A, LI X, et al. [J]. Bioorg Med Chem Lett, 2007, 17(15): 4254-4257.
  • 7ZHU S, JI S, SU X, et al. [J]. Tetrahedron Lett, 2008, 49(11): 1777-1781.
  • 8FARGHALY A M, HABIB N S, KHALIL M A, et al. [J]. Alex J Pharm Sci, 1989, 3(1) : 90-94.
  • 9SHIRI M. [J]. Chem Rev, 2012, 112(6): 3508-3549.
  • 10HUMPHREY G R, KUETHE J T. [J]. Chem Rev, 2006, 106(7) .. 2875-2911.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部